Results of lithium-131I treatment of thyrotoxicosis
The role of lithium as an adjunct to 131I therapy of thyrotoxicosis has been assessed. Seventeen lithium-131I treated patients and 16 control — 131I treated patients have been followed for almost three years. Five lithium — 131I and 3 control — 131l patients have become hypothyroid with the lithium treated patients developing earlier thyroid failure. Ten lithium and 10 control patients remain clinically and biochemically euthyroid. Two lithium — 131I and 2 control — 131I patients remain on low dose antithyroid drugs.
Key-wordsLithium 131I treatment thyrotoxicosis
- 3.Sadler W.A., Brownlie B.E.W., Triiodothyronine radioimmunoassay in the assessment of thyroid function. N.Z. Med. J. 81: 320, 1975.Google Scholar
- 4.Donald R.A., Brownlie B.E.W., Espiner E.A., Rutledge D. Measurement of pituitary hormones: clinical applications 4. Thyroid stimulating hormone. N.Z. Med. J. 78: 204, 1973.Google Scholar